Decision journal · HALO — Halozyme

On plan, working

Opened 50 days ago and still held. No engine recommendations are logged on this name yet. It stands up +$3,979 (+16.9%) with the stop at $62.12.

Unrealized

+$3,979 (+16.9%)

Realized

Weight · held

14.7% · 50d

Engine followed

—

assembled from the book, the realized-outcome ledger, the decision ledger, the event feed, and the thesis — one connected record, graded nightly

Every call on this timeline is graded against a later mark — pending until reality answers.

XLE

TSM

KGC

MCD

CME

The life of the position

June 11, 2026Opened
Opened 333 @ 70.59
Royalty stream from partnered drug-delivery technology.
Size $23,506Avg cost $70.59Initial stop $62.12Planned risk $2,821 (-12.0%)
July 31, 2026Now
Held: 333 @ 82.54
Thesis breaks if: A key partner drug fails or is delisted.
Unrealized $3,979.35 (+16.9%)Stop $62.12Weight 14.7%

Assembled from the connected record — the book, the realized-outcome ledger, the decision journal, the event feed, and the thesis. Grades stay pending until a later mark exists; nothing here is a recommendation. Not investment advice.